163 related articles for article (PubMed ID: 36749556)
1. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.
Parente A; Kamarajah SK; Baia M; Tirotta F; Manzia TM; Hilal MA; Pawlik TM; White SA; Dahdaleh FS
J Gastrointest Surg; 2023 Apr; 27(4):741-749. PubMed ID: 36749556
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study.
Kamarajah SK; Al-Rawashdeh W; Parente A; Atherton P; Salti GI; Dahdaleh FS; Manas D; Hilal MA; White SA
Eur J Surg Oncol; 2022 Jun; 48(6):1300-1308. PubMed ID: 34916085
[TBL] [Abstract][Full Text] [Related]
3. A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy.
Ito T; Butler JR; Noguchi D; Ha M; Aziz A; Agopian VG; DiNorcia J; Yersiz H; Farmer DG; Busuttil RW; Hong JC; Kaldas FM
Liver Transpl; 2022 Mar; 28(3):386-396. PubMed ID: 34482610
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
5. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection.
Hassan H; Chakrabarti S; Zemla T; Yin J; Wookey V; Prasai K; Abdellatief A; Katta R; Tran N; Jin Z; Cleary S; Roberts L; Mahipal A
Eur J Surg Oncol; 2023 Nov; 49(11):106994. PubMed ID: 37524649
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
8. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
10. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
Sutton TL; Billingsley KG; Walker BS; Enestvedt CK; Dewey EN; Orloff SL; Mayo SC
Am J Surg; 2021 Jun; 221(6):1182-1187. PubMed ID: 33707077
[TBL] [Abstract][Full Text] [Related]
12. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
[TBL] [Abstract][Full Text] [Related]
15. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
Wirasorn K; Ngamprasertchai T; Khuntikeo N; Pakkhem A; Ungarereevittaya P; Chindaprasirt J; Sookprasert A
J Gastroenterol Hepatol; 2013 Dec; 28(12):1885-91. PubMed ID: 23829232
[TBL] [Abstract][Full Text] [Related]
18. Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma.
Kida A; Mizukoshi E; Kitahara M; Miyashita T; Goto S; Kamigaki T; Takimoto R; Asai J; Kakinoki K; Urabe T; Tomita K; Kaneko S
Int J Cancer; 2024 Feb; 154(4):738-747. PubMed ID: 37676069
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
[TBL] [Abstract][Full Text] [Related]
20. [Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer].
Rademacher S; Denecke T; Berg T; Seehofer D
Chirurgie (Heidelb); 2022 Jul; 93(7):644-651. PubMed ID: 35771272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]